Ginkgolide C

Interesting facts

Exploring 7-(3-furyl)-19-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadec-13-ene-5,15-dione

This intriguing compound is a member of a unique family of organic molecules characterized by an intricate structure and a variety of functional groups. Here are some fascinating points about this compound:

• Complex Structure: The compound features a pentacyclic framework, which is notable for its highly fused ring system. This complexity often translates to interesting physical and chemical properties.
• Furan Ring Influence: The presence of a 3-furyl moiety introduces significant aromatic character, which may influence its reactivity and interactions. Furans are known for their diverse applications in organic synthesis and medicinal chemistry.
• Hydroxy Group Versatility: The hydroxy group at the 19-position can participate in a variety of chemical reactions, making it a potential site for further derivatization or functionalization. Hydroxy groups are important in enhancing the polarity and solubility of organic compounds.
• Potential Biological Activity: Compounds of this nature often exhibit interesting biological properties, and variations of pentacyclic compounds have been investigated for *anticancer, antifungal,* and *antibacterial* activity. This makes such compounds worthy of study in medicinal chemistry.
• Stereochemistry Considerations: The structural complexity also implies several possible stereoisomers, which can lead to variations in biological activity. The stereoelectronic effects introduced by different substituents can have profound impacts on a compound's properties.

In summary, 7-(3-furyl)-19-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadec-13-ene-5,15-dione is not just a chemical entity but a fascinating subject that bridges the fields of organic chemistry, pharmacology, and materials science. As research continues, uncovering its potential applications in various fields could lead to significant advancements.